Sangfroid Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-11-2024
- Paid Up Capital ₹ 0.10 M
as on 05-11-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Ebitda
- Net Worth -12.99%
(FY 2023)
- Total Assets 0.69%
(FY 2023)
About Sangfroid Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Basavaraju Krishna, Shabarish Jagarapu, and Mahender Bahuganam serve as directors at the Company.
- CIN/LLPIN
U24232TG2012PTC083530
- Company No.
083530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sangfroid Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shabarish Jagarapu  | Director | 10-Oct-2012 | Current |
| Basavaraju Krishna | Director | 10-Oct-2012 | Current |
| Mahender Bahuganam | Director | 10-Oct-2012 | Current |
Financial Performance of Sangfroid Pharma.
Sangfroid Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sangfroid Pharma?
Unlock access to Sangfroid Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Degradable Polymer Technologies Private LimitedActive 14 years 4 months
Shabarish Jagarapu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sangfroid Pharma?
Unlock and access historical data on people associated with Sangfroid Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sangfroid Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sangfroid Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.